The Supreme Court has heard oral argument in Oil States v. Greene’s Energy, and a decision whether IPRs are unconstitutional is currently pending. For companies currently embroiled in IPRs that could directly impact their bottom line, the Supreme Court’s decision could be very tangible. AbbVie ($ABBV) and Coherus Biosciences ($CHRS) are a case in point.
Read MoreIn the course of eviscerating IPRs through Oil States, pharma could theoretically open the door to jury trials for its patents. That may not be a good thing for branded pharma.
Read More